Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Motor Units00:46

Motor Units

A motor unit consists of two main components: a single efferent motor neuron (i.e., a neuron that carries impulses away from the central nervous system) and all of the muscle fibers it innervates. The motor neuron may innervate multiple muscle fibers, which are single cells, but only one motor neuron innervates a single muscle fiber.
Motor Units01:13

Motor Units

The motor unit is a fundamental component of the neuromuscular system and plays a crucial role in coordinating muscle contractions. It consists of a somatic motor neuron, which connects and controls multiple skeletal muscle fibers, forming a single functional segment. The axon of the motor neuron branches out and establishes synaptic connections known as neuromuscular junctions with individual muscle fibers within the motor unit.
Motor units come in different sizes, with smaller units...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome.

Journal of neurology·2023
Same author

Distal symmetric polyneuropathy phenotype in patients with sensory neuronopathy at the time of electrodiagnosis.

Muscle & nerve·2022
Same author

Patients who meet electrodiagnostic criteria for CIDP rarely present with a sensory predominant DSP phenotype.

Muscle & nerve·2021
Same author

Electrophysiological Changes After Human Muscle Tear: A Potential Confounder.

American journal of physical medicine & rehabilitation·2019
Same author

Does cerebrospinal fluid analysis have a meaningful role in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy?

Muscle & nerve·2019
Same author

Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.

Journal of clinical apheresis·2015
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

Multifocal motor neuropathy.

Dustin G Nowacek1, James W Teener

  • 1Department of Neurology, University of Michigan Health System, Ann Arbor, MI 48109-5036, USA.

Seminars in Neurology
|May 17, 2013
PubMed
Summary
This summary is machine-generated.

Multifocal motor neuropathy causes progressive weakness due to autoimmune attacks on motor nerves. Early diagnosis is crucial as it responds well to treatments like intravenous immunoglobulin, unlike corticosteroids.

More Related Videos

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Related Experiment Videos

Last Updated: May 11, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multifocal motor neuropathy (MMN) is an acquired neurological disorder.
  • It involves demyelination and axonal damage of motor neurons, often mimicking motor neuron disease.
  • MMN is characterized by progressive, painless weakness without sensory loss.

Purpose of the Study:

  • To highlight the critical importance of recognizing multifocal motor neuropathy.
  • To emphasize its distinct clinical presentation and response to treatment.

Main Methods:

  • The abstract does not specify methods but describes the clinical characteristics and treatment responses of MMN.
  • Information is based on established clinical understanding and treatment outcomes.

Main Results:

  • Multifocal motor neuropathy is frequently mistaken for motor neuron disease.
  • MMN demonstrates significant responsiveness to specific treatments.
  • Intravenous immunoglobulin (IVIg) is the primary treatment of choice.
  • Other immunosuppressive therapies may offer benefits.

Conclusions:

  • Early identification of MMN is essential for effective management.
  • Prompt treatment leads to favorable outcomes.
  • Corticosteroids appear to provide minimal therapeutic benefit in MMN.